Cargando…
Anti-angiogenic therapy in ovarian cancer: Current understandings and prospects of precision medicine
Ovarian cancer (OC) remains the most fatal disease of gynecologic malignant tumors. Angiogenesis refers to the development of new vessels from pre-existing ones, which is responsible for supplying nutrients and removing metabolic waste. Although not yet completely understood, tumor vascularization i...
Autores principales: | Mei, Chao, Gong, Weijing, Wang, Xu, Lv, Yongning, Zhang, Yu, Wu, Sanlan, Zhu, Chunqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027942/ https://www.ncbi.nlm.nih.gov/pubmed/36959862 http://dx.doi.org/10.3389/fphar.2023.1147717 |
Ejemplares similares
-
Anti-angiogenic Therapy in Cancer: Downsides and New Pivots for Precision Medicine
por: Lupo, Gabriella, et al.
Publicado: (2017) -
Anti-angiogenic therapy in ovarian cancer: current situation & prospects
por: Liu, Yinping, et al.
Publicado: (2021) -
Editorial: Ovarian cancer-targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more
por: Wang, Zhi-Bin, et al.
Publicado: (2023) -
Targeting Angiogenesis in Breast Cancer: Current Evidence and Future Perspectives of Novel Anti-Angiogenic Approaches
por: Ayoub, Nehad M., et al.
Publicado: (2022) -
Application of Population Pharmacokinetic Analysis to Characterize CYP2C19 Mediated Metabolic Mechanism of Voriconazole and Support Dose Optimization
por: Li, SiChan, et al.
Publicado: (2022)